Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
Bert van Meurs, Chief Business Leader Image Guided Therapy and Member of the Executive Committee at Royal Philips, shared on LinkedIn:
”New late-breaking results from the iMODERN trial, presented at TCT 2025, bring important clarity for heart attack patients with multi-vessel disease.
This global study confirms that treating additional lesions during the initial procedure is just as safe as waiting to stage treatment, giving clinicians more flexibility to tailor care to each patient’s needs.
Complementary findings from the ILIAS ANOCA study also highlight the value of physiology-guided assessment and personalized therapy for patients with angina but no obstructive coronary arteries, resulting in sustained improvements in quality of life.
I’m proud that Philips solutions supported both of these impactful studies.
Together with our clinical partners, we’re helping advance evidence-based, individualized cardiovascular care for patients worldwide.”
Read the full announcement here.
Stay updated on all scientific advances with Hemostasis Today.
-
May 14, 2026, 17:17Abhijit D: Reticulocyte Count Methods in Hematology Laboratories
-
May 14, 2026, 16:46Michele Romoli: Neurointerventional Workforce Gaps and Stroke Thrombectomy Access in Europe
-
May 14, 2026, 16:37Reyes Calzada Bau: What It Means to Live with Immune Thrombocytopenia
-
May 14, 2026, 16:34Julia Owens: Improving Acute Stroke Care for Patients Without Timely Intervention
-
May 14, 2026, 16:28Krish Patel։ Opioid Overdose and Heart-Related Deaths in the USA (1999–2023)
-
May 14, 2026, 16:26Carla Goulart Peron: 79th World Health Assembly Momentum for Global Stroke Action
-
May 14, 2026, 16:21Love Preet Kalra: Honored to Present Our Data on Plasma GFAP Measurements for ICH at ESOC 2026
-
May 14, 2026, 16:09Dino Mehic: BDUC and Its Overlap With Inherited and Rare Bleeding Disorders
-
May 14, 2026, 16:06Silvia Escribano Serrat: Flow Cytometric Osmotic Fragility Testing for Diagnosis of Hereditary Spherocytosis